This study suggests that any therapeutic benefits that they display are more likely due to increased endothelial expression of the important pro-angiogenic factors PGF, VEGF and ADM, and through mitigation of inflammatory changes that occur subsequent to endothelial dysfunction, rather than through regulation of placental anti-angiogenic factor secretion, which was only modestly affected at best. Here, PGF is linked to endothelial dysfunction.